ArticleBioorganic & medicinal chemistry letters2018

Discovery of 2-arylquinazoline derivatives as a new class of ASK1 inhibitors.

Andrii Monastyrskyi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.